Navigation Links
Combining brain imaging, genetic analysis may help identify people at early risk of Alzheimer's
Date:2/8/2011

For Immediate Release February 8, 2011 - (Toronto) A new study from the Centre for Addiction and Mental Health (CAMH) has found evidence suggesting that a variation of a specific gene may play a role in late-onset Alzheimer's, the disease which accounts for over 90% of Alzheimer's cases. This innovative study has combined genetics and brain imaging to determine who may be at risk for developing late-onset Alzheimer's disease long before symptoms appear.

The gene, which is called brain-derived neurotrophic factor (BDNF), is crucial to maintaining healthy function of the brain, primarily the brain's memory centre of the hippocampus and entorhinal cortex, and is responsible for learning and memory function. Past research has found that less BDNF is present in the memory centre of those diagnosed with Alzheimer's disease. However genetic association studies alone have not produced definite findings regarding this gene. Instead, a combination of genetics and brain imaging were used to demonstrate clear effects of this gene in the brain.

In the study published today in the Archives of General Psychiatry, a variation of the BDNF gene called val66met, was tracked and examined in healthy individuals to see what effect it had on the brain. Genotyping was used to determine which study participants carried the gene variation. Then two types of brain imaging -- high-resolution magnetic resonance imaging (MRI) cortical thickness mapping and diffusion tensor imaging (DTI) (an MRI-based technique that measures key structural connections in the brain)-- were applied to measure the physical structures of the brain in each individual. This combination of genetic screening and imaging found that BDNF val66met gene variation influenced exactly those brain structures and connections that deteriorate at the earliest phases of Alzheimer's disease.

"Our sample consisted of healthy adults who passed all cognitive testing and displayed no clinical sym
'/>"/>

Contact: Michael Torres
media@camh.net
416-595-6015
Centre for Addiction and Mental Health
Source:Eurekalert

Page: 1 2

Related biology news :

1. Combining sun, sand and science in the Bahamas
2. Ecology in organic ag: Combining farming, science
3. Combining nanotubes and antibodies for breast cancer search and destroy missions
4. Muscle mass in elderly boosted by combining resistance exercise and blood flow restriction
5. Penn biophysicists create new model for protein-cholesterol interactions in brain and muscle tissue
6. During exercise, the human brain shifts into high gear on alternative energy
7. Millisecond brain signals predict response to fast-acting antidepressant
8. Food for thought -- regulating energy supply to the brain during fasting
9. Risk and reward compete in brain
10. Brainy genes, not brawn, key to success on mussel beach
11. Brain-nourishing molecule may predict schizophrenia relapse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2015)... March 11, 2015   The Sync Project™ ... to scientifically measure and harness music to improve ... biometrics and objective measurements of physiology, enabling the ... scale in large populations. It is designed for ... clinicians perform rigorous studies and accelerate the discovery ...
(Date:3/10/2015)... 2015   Tute Genomics , pioneer in affordable, ... next-generation sequencing company PrimBio Research Institute to ... gene panel interpretation. PrimBio, a certified Life ... current technologies to support the work of experts on ... two types of exome sequencing services: 1) Targeted Exome ...
(Date:3/4/2015)... 04, 2015 Research and Markets ... the "Global Biometrics Market Forecast and Opportunities, ... The market for biometric authentication systems is projected ... till 2020 The driving forces for ... needs, government projects and constant development in technology. ...
Breaking Biology News(10 mins):Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3
... BOSTON -- David Mooney, Ph.D., a core faculty member at ... and the Robert P. Pinkas Family Professor of Bioengineering at ... elected to the Institute of Medicine (IOM) of the National ... field of medicine in the United States. The IOM ...
... tons of crushing force and volcanic heat to forge ... a way to cheaply make nanodiamonds on a lab ... The nanodiamonds are formed directly from a gas and ... holds promise for many uses in technology and industry, ...
... is available in German . ... the European region preliminary round of the international iGEM competition. The ... has developed to generate energy directly from bacteria that they judged ... dreamed that we would win, says Lukas Rositzka, a member of ...
Cached Biology News:Wyss Institute core faculty member elected to the Institute of Medicine of the National Academies 2CWRU makes nanodiamonds in ambient conditions 2CWRU makes nanodiamonds in ambient conditions 3CWRU makes nanodiamonds in ambient conditions 4Bielefeld iGEM team wins European preliminary round 2
(Date:3/27/2015)... York (PRWEB) March 27, 2015 Governor ... 2015 application period for 43North - the world’s largest ... including a grand prize of $1 million, six $500,000 ... from around the world to compete for prizes that ... enterprises in the Western New York region. , ...
(Date:3/26/2015)... , March 26, 2015 /PRNewswire/ - SQI Diagnostics ... announced that after dealing with certain matters, including the ... shareholders held on March 26, 2015 (the "Meeting") was ... April 8, 2015 at 11:00 a.m. ( Toronto ... has been changed from that previous disclosed. The Meeting ...
(Date:3/26/2015)... Massachusetts and CINCINNATI ... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... a three-year, broad research collaboration for rare diseases. The ... develop novel therapies to treat rare diseases with ... commercialization capabilities with Cincinnati Children,s research expertise. As ...
(Date:3/26/2015)... 2015 ReliantHeart, Inc., an innovative supplier ... supplier of precision transit-time flow measurement solutions, are collaborating ... the efficiency of the HeartAssist5® Left Ventricular ... experience greater mobility and peace of mind. , ... board, will draw 1/6th of the power required by ...
Breaking Biology Technology:Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 4Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 5SQI Diagnostics Inc. Announces Adjournment of Meeting 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 4Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 5LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3
... backdrop of a flagging,economy, bailouts, and bleak predictions, ... a future as bright as New Year,s Eve ... the Embozene(TM),Color-Advanced Microspheres embolization platform for the treatment ... blood vessels in many,locations) and arteriovenous malformations (defects ...
... Calif., Dec. 31 Nektar Therapeutics,(Nasdaq: ... closed the divestiture,of specific Nektar pulmonary delivery assets, ... in cash. The transaction was completed,on December 31, ... closing, Novartis assumes ownership of certain dry powder ...
... & Drug,Administration (FDA) today approved a new nucleic acid test ... hepatitis C RNA and hepatitis B,DNA in a single, automated ... on the cobas s 201 system, is a qualitative in ... HIV-1 Group O RNA,HIV-2 RNA, hepatitis C Virus RNA and ...
Cached Biology Technology:First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform 2First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform 3First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform 4Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million 2FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C 2FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C 3
Rabbit polyclonal to Methionine Aminopeptidase 2 ( Abpromise for all tested applications). entrezGeneID: 10988 SwissProtID: P50579...
Mouse monoclonal [TU-20] to beta III Tubulin (FITC) ( Abpromise for all tested applications). entrezGeneID: 10381 SwissProtID: Q13509...
Chlamydia pneumoniae (TWAR)...
Sheep polyclonal to Methaqualone ( Abpromise for all tested applications). Antigen: Methaqualone(5') conjugated to BSA...
Biology Products: